![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 41, 29042-29049, October 8, 1999
,From the Department of Neurobiology, University of Heidelberg, Im Neuenheimer Feld 364, 69120 Heidelberg, Germany
| |
ABSTRACT |
|---|
|
|
|---|
In many cell types, glycosylphosphatidylinositol
(GPI)-anchored proteins are sequestered in detergent-resistant membrane
rafts. These are plasma membrane microdomains enriched in
glycosphingolipids and cholesterol and are suggested to be platforms
for cell signaling. Concomitant with the synthesis of myelin
glycosphingolipids, maturing oligodendrocytes progressively associate
GPI-anchored proteins, including the adhesion molecules NCAM 120 and
F3, in rafts. Here we show that these microdomains include Fyn and Lyn
kinases. Both kinases are maximally active in myelin prepared from
young animals, correlating with early stages of myelination. In the
rafts, Fyn kinase is tightly associated with NCAM 120 and F3. In
contrast, in oligodendrocyte progenitor cells lacking rafts or in
raft-free membrane domains of more mature cells, F3 does not associate
with Fyn. The addition of anti-F3 antibodies to oligodendrocytes
results in stimulation of Fyn kinase specifically in rafts.
Compartmentation of oligodendrocyte GPI-anchored proteins in rafts is
thus a prerequisite for association with Fyn, permitting kinase
activation. Interaction of oligodendrocyte F3 with axonal ligands such
as L1 and ensuing kinase activation may play a crucial role in
initiating myelination.
The formation of a myelin sheath is essential for the rapid
saltatory propagation of action potentials in the vertebrate nervous system (1). Myelination in the central nervous system involves sequential stages of interaction between the myelinating glial cell,
the oligodendrocyte, and the neuronal process, the axon. Initial
recognition and adhesion results in wrapping of the glial process
around the axon (ensheathment) followed by the laying down of the
multilamellar sheath. Although progenitor cells have the intrinsic
potential to differentiate into oligodendrocytes in vitro in
the absence of axons (2-4), myelination in vivo
demonstrates a high degree of specificity and requires axonal signals.
For example, oligodendrocytes do not normally myelinate dendrites (5,
6). Cell adhesion molecules expressed by both axons and glial cells are
known to play a crucial role in the establishment of axon-glial contact
and subsequent signaling to the oligodendrocyte, driving the process of
myelination (7, 8). In turn, the myelinating glial cell triggers an
axonal reaction, culminating in an increased phosphorylation of
neurofilaments and regulation of the axonal diameter (9, 10).
Members of the cadherin and the Ig superfamily such as L1,
NCAM,1 and especially MAG are
candidate molecules mediating axon-glial interactions (7, 11). The
formation of morphologically normal myelin sheaths in MAG knockout and
even in MAG/NCAM double knockout mice suggests that either these
molecules are not involved in myelin formation or additional molecules
participate in the early events of myelination (12-14). Our knowledge
about the signals exchanged between axons and oligodendrocytes during
myelination is also incomplete. A role for oligodendroglial Fyn kinase
(a nonreceptor tyrosine kinase of the Src family) has been proposed as
Fyn phosphorylates MAG after co-transfection in COS cells and Fyn
knockout mice are hypomyelinated (15). The integrity of the axon-glial
unit requires continual bidirectional signaling between the
oligodendrocyte and the axon.
GPI-anchored proteins expressed by oligodendrocytes and their precursor
cells are candidates for recognition molecules dictating the initial
interactions between axon and oligodendrocyte and acting as receptors
mediating axon-glial signal transduction. Oligodendrocyte precursor
cells express a distinct pattern of GPI-anchored molecules, which is
retained as the cells mature and is present in preparations of adult
myelin. Although both oligodendrocyte precursor cells and mature
oligodendrocytes express a similar pattern of GPI-anchored proteins, in
oligodendrocytes and myelin, but not in precursor cells, these proteins
are associated with the major myelin lipids galactocerebroside,
sulfatide, and cholesterol in membrane domains. These domains can be
isolated as detergent-insoluble glycosphingolipid-rich microdomains
(DIGs) by sucrose density gradient centrifugation (16). DIGs can be isolated from several cell types and are thought to represent raft-like
microdomains within the plasma membrane, resulting from the lateral
assembly of sphingolipids and cholesterol in the exoplasmic leaflet of
the lipid bilayer due to weak interactions between their polar
headgroups (17, 18). In polarized epithelial cells, where rafts emerge
in the trans-Golgi network, they are thought to be responsible for the
apical sorting of glycosphingolipids, GPI-anchored proteins, and other
apical marker molecules (17-19). We postulated that in
oligodendrocytes, as in epithelial cells, DIGs represent raftlike
membrane domains in which oligodendrocyte GPI-anchored proteins
together with the major myelin lipids are sorted into the forming
myelin sheath (16). Mice in which the enzyme UDP-galactose:ceramide
galactosyl transferase catalyzing the synthesis of the myelin lipids
galactocerebroside and sulfatide has been knocked out exhibit tremors
and hind limb paralysis and die prematurely (20, 21). They show
deficits in nerve conduction despite the formation of compact myelin.
However, the nodal/paranodal structure in these mice is severely
perturbed (22, 23). Whether these defects result from a loss of
functional properties of these lipids such as insulation or from the
loss of lipid-associated targeting of specific proteins including
signaling molecules to areas of the forming myelin sheath is unelucidated.
As was first shown for T-lymphocytes, in many cell types DIG
microdomains include nonreceptor tyrosine kinases of the Src family
(24, 25). In this paper, we investigated the association of such
kinases with GPI-anchored proteins in oligodendrocytes and myelin,
since they could be involved in signal transduction between the
wrapping glial cell process and the axon. Our results show that the two
major oligodendroglial GPI-anchored proteins, the 120-kDa isoform of
NCAM (26, 27) and F3 (28-30), both members of the Ig superfamily of
adhesion molecules, colocalize with the Src family kinases Fyn and Lyn
in oligodendrocyte and myelin DIGs. The activity of both kinases within
the DIGs is developmentally regulated, being most active at the
beginning of myelination. Fyn but not Lyn kinase activity is stably
associated with both NCAM 120 and F3. Furthermore, antibody-mediated
cross-linking of F3 results in stimulation of the Fyn kinase activity
localized to oligodendrocyte DIGs. The association of NCAM 120 and F3
with Fyn kinase to a functional signaling complex within raftlike
glycosphingolipid-rich microdomains during oligodendrocyte maturation
may be critical for signal transduction between axon and glial cell in
the early phases of myelination.
Materials and Antibodies--
Radiochemicals
([
The following rabbit polyclonal antibodies were used: antibodies
recognizing NCAM (27), F3 (Ig fraction of a serum raised against the
N-terminal F3 peptide; Ref. 29), the AN2 antigen (31), Fyn, and Lyn
(Santa Cruz Biotechnology, Inc., Heidelberg). The following monoclonal
antibodies were used: murine monoclonal antibody 27-11-111 (mAb F11 No.
8) made against chick F11 (32), which cross-reacts with mouse F3 (56),
kindly provided by Dr. F. Rathjen (Berlin, Germany); rat monoclonal
antibody AN2, which recognizes a surface epitope of a 330-kDa
glycoprotein expressed by the cell line Oli-neu and primary
oligodendrocyte progenitors (31); murine monoclonal antibody 4G10
against phosphotyrosine from Upstate Biotechnology, Inc. (Lake Placid,
NY); and mouse monoclonal antibody against Fyn (Pharmingen/Transduction
Laboratories). Secondary antibodies were from Dianova (Hamburg, Germany).
Cell Cultures and Metabolic Labeling--
Primary cultures of
oligodendrocytes were prepared from embryonic day 14-16 mice as
described (27, 33). Oligodendrocytes growing on top of astrocyte
monolayers were shaken off and plated in modified Sato medium (27)
containing 1% horse serum on poly-L-lysine-coated dishes.
To increase the proportion of precursor cells as well as to promote
survival, 10 ng/ml human recombinant platelet-derived growth factor
(AA), and 5 ng/ml basic fibroblast growth factor were added immediately
after the shake and after 24 h in vitro. Oligodendrocytes were kept for 5 days in vitro without
further growth factor additions before they were harvested. The
resulting population, which was used for all experiments with primary
cultures, is enriched for differentiated oligodendrocytes but contains
a fraction of progenitor cells (27). The cell line Oli-neu
(34) was cultured in Sato medium containing 1% horse serum. To induce differentiation of the precursor-like Oli-neu cells,
cultures were treated with 1 mM dbcAMP for 3-4 days
(daily additions to the culture medium).
For metabolic labeling primary oligodendrocytes and Oli-neu
cells were starved for 1 h in SO4/Met/Cys-free DMEM
and incubated for 4 h with 100 µCi/ml
L-[35S]Met/Cys labeling mix.
Myelin Preparation--
Myelin was isolated from the brains of
young postnatal (postnatal days (P)9/10, P12, P16, P20, P30, or P45)
and adult NMRI mice of both sexes according to standard procedures (35,
36). Initially, brains were homogenized in ice-cold 10.5% sucrose
using the Ultra-Turrax T25 (IKA, Staufen, Germany). Myelin was removed from the interface between 10.5 and 30% sucrose step gradients and
subjected to two rounds of hypoosmotic shock by resuspension in a large
volume of ice-cold water and reisolation on the step gradient; this
separates myelin membranes from axolemma. Purified myelin was collected
from the final sucrose interface, washed twice with cold water,
resuspended in a small volume of water, and immediately used or frozen
in small aliquots at Preparation of Detergent Extracts and Sucrose Density Gradient
Centrifugation--
Detergent extracts were prepared as described (19,
37). In brief, primary oligodendrocytes (2-3 × 107)
or sonicated myelin (300 µg of total protein) were solubilized at
4 °C in 1 ml of extraction buffer containing 10 mM
Tris/HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, and 2% Triton X-100
(TNE/Triton X-100). The extracts were shaken for 30 min at 4 °C.
Detergent extracts were adjusted to 40% sucrose by adding equal
volumes of 80% sucrose in TNE without Triton X-100 and placed into an
ultracentrifuge tube. A linear gradient from 5 to 30% sucrose (in TNE
without Triton X-100) was layered over the lysate. Gradients were
centrifuged for 12 h at 35,000 rpm at 4 °C in a Beckmann SW 40 TI rotor (218,000 × g). 1-ml fractions were harvested,
and the density was determined by measurement of the refractive index.
Proteins in each fraction were analyzed by SDS-PAGE followed by Western
blot. Light gradient fractions containing floating GPI-anchored
proteins, glycosphingolipids, and cholesterol (DIGs) were collected,
diluted with double distilled H2O, and pelleted for 1 h at 218,000 × g and 4 °C. Isolated DIGs were
subjected to an in vitro kinase assay and
immunoprecipitation. The protein concentration of the DIGs was
evaluated with the Bio-Rad protein assay kit using bovine serum albumin
as a protein standard.
Immunoblotting--
Proteins blotted onto polyvinylidene
difluoride membrane were detected by incubation with primary antibodies
overnight at 4 °C. The blots were incubated with a second
anti-species antibody conjugated with HRP for 30-60 min at room
temperature. The blots were developed with ECL reagents according to
the manufacturer's instructions.
Membranes were stripped with 100 mM glycine, pH 2, for 30 min, blocked, and reprobed with antibodies.
Immunoprecipitation from DIGs and Bottom Fractions of the
Gradients--
Isolated DIGs were resuspended in 0.5 ml of lysis
buffer (50 mM Tris/HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1 mM Na3VO4, 1 mM NaF, 1 mM phenylmethylsulfonyl fluoride, and
1% Nonidet P-40), incubated with antibodies and Protein A-Sepharose
and washed under stringent conditions in radioimmune
precipitation buffer (50 mM Tris/HCl, pH 7.4, 1% Triton
X-100, 1% sodium deoxycholate, 0.1% SDS, 1 mM
dithioerythritol, 100 µM Na3VO4,
10 mM NaF) and once in 50 mM Tris/HCl, pH 7.4, 100 µM Na3VO4, 10 mM
NaF. The immunoprecipitate was subjected to a
[
DIGs that had been subjected to a [
For immunoprecipitation from bottom fractions of the gradients, 250 µl of the fraction was diluted with an equal volume of lysis buffer
and processed similarly to the DIG fractions above.
In Vitro Kinase Assay--
Immune complexes were resuspended in
20 µl of kinase buffer (20 mM HEPES, pH 7.4, 5 mM MgCl2, 1 mM MnCl2,
100 µM Na3VO4) and incubated with
5 µCi of [
DIGs were isolated from sucrose density gradients, resuspended in 50 µl of kinase buffer, and incubated with 10 µCi of
[ Densitometry--
Optical densities from linear exposures of
autoradiograms and Western blots developed using ECL were measured
using the UltraScan XL Laser Densitometer (Amersham Pharmacia Biotech)
and the GelScan XL software. Kinase activities were expressed as a
function of tyrosine phosphorylation in relation to the total amount of
the kinase.
Antibody-mediated Cross-linking--
Oli-neu cells
(1-2 × 107) were induced to differentiate by
incubation with 1 mM dbcAMP for 3-4 days (34). The cells
were washed twice with ice-cold Tris-buffered saline and incubated for
1 h at 4 °C with the monoclonal antibody 27-11-111, which reacts with F3 (32). The cells were washed three times with ice-cold
Tris-buffered saline and incubated with rabbit anti-mouse IgG for 30 min at 4 °C. In control samples, cells were incubated with the
monoclonal AN2 antibody (31), followed by rabbit anti-rat IgG, or with
primary or secondary antibodies alone. Subsequently, the dishes were
transferred to 37 °C for 0, 3, 5, and 10 min (controls were left for
5 min at 37 °C). Following incubation at 37 °C, the cells were
immediately lysed in 1.5 ml of extraction buffer, and the extracts were
subjected to sucrose density gradient centrifugation as described
above. DIGs were isolated from sucrose density gradients, subjected to
SDS-PAGE, and analyzed by immunoblotting for tyrosine-phosphorylated Fyn and total Fyn protein with specific antibodies.
GPI-anchored Proteins and Src Family Kinases Colocalize in
Detergent-insoluble Glycosphingolipid-rich Microdomains during
Development of the Myelin Sheath--
To examine the localization of
GPI-anchored proteins in DIGs during myelination, primary
oligodendrocytes or myelin prepared from mice at defined developmental
stages between postnatal day 9 (P9) and adult were analyzed by
detergent extraction and sucrose density gradient centrifugation. Equal
amounts of total myelin protein from each age examined were applied to
the gradients. Western blot analysis of the gradient fractions with
antibodies recognizing NCAM or F3 showed that a fraction of both
GPI-anchored NCAM 120 and F3 float at low densities in the gradient
(Fig. 1A). Transmembrane
isoforms of NCAM (NCAM 140 and 180) localize exclusively at the bottom
of the gradient in high density fractions. Lipid analysis showed that
the low density fractions are enriched in the typical myelin
glycosphingolipids galactocerebroside and sulfatide as well as
cholesterol (16). Flotation of GPI-anchored proteins in the gradient
shows their specific association with DIGs. DIGs from cultured
oligodendrocytes and myelin of P9/10 and P12 mice are distributed in
gradient fractions between 18 and 25% sucrose (fractions 4-9). With
increasing age of the animals and thus progressing myelination, the
myelin DIGs focus at a density of 17-18% sucrose (fractions 8 and 9).
The GPI-anchored proteins are enriched in DIGs and in myelin from P45,
and they are localized exclusively in DIGs.
Western blot analysis of the gradient fractions with antibodies against
the Src family tyrosine kinases Fyn (p59) and Lyn (p53/56) showed that
both kinases co-localize with NCAM 120 and F3 in DIG fractions (Fig.
1B). In gradients from cultured primary oligodendrocytes and
myelin from P9/10 and P12 animals both kinases were found in bottom
gradient fractions as well as in DIG fractions, in a distribution
similar to that of the GPI-anchored proteins. The expression of Lyn
kinase in myelin declined after P12, whereas Fyn was still expressed in
adult myelin. With progressing myelination, Fyn kinase became
progressively associated with DIG fractions, and in myelin from P30 up
to adult it localized exclusively to DIGs, in a similar fashion to the
shift in localization of the GPI-anchored proteins.
Fyn and Lyn Kinase Activity in Oligodendrocyte and Myelin DIGs
Peaks at the Onset of Myelination--
Immunoprecipitation of
phosphoproteins from the [ Fyn Co-immunoprecipitates with the GPI-anchored Proteins NCAM 120 and F3 from Oligodendrocyte DIGs--
We next asked whether the
co-localization of the GPI-anchored adhesion receptors and the Src
kinases on sucrose density gradients reflects an association between
these molecules. We isolated DIGs from oligodendrocyte extracts, used
them as a source for immunoprecipitation of NCAM or F3, and performed a
[
In contrast to the multiple signals seen when the entire DIG proteins
were subjected to a kinase assay (data not shown), a dominant
phosphorylated protein of 59 kDa was associated with the
immunoprecipitated NCAM 120 and F3 in DIGs (Fig.
3A, lane 5, and Fig. 3B, lane 5). In
both cases, this 59-kDa phosphoprotein was identified as Fyn kinase by
reprecipitation with specific antibodies (Fig. 3, A,
lane 6, and B, lane
6). No association with Lyn kinase was observed (data not
shown). Additional signals of higher molecular weight were observed in
the autoradiograph of the kinase assay on the NCAM 120 immunoprecipitate, but these were weak in comparison with the 59-kDa
Fyn signal. In the case of the kinase assay on the F3
immunoprecipitate, additional signals were hardly visible. The
precipitation and washing conditions were thus stringent enough (0.1%
SDS in the washing buffer) to destroy the structural integrity of DIGs
but did not perturb the association between Fyn and NCAM 120 or Fyn and
F3. Similar analysis of the bottom fractions from the gradient showed
that Fyn kinase activity was lacking in the NCAM or F3
immunoprecipitates (Fig. 3, A, lanes 2 and 3, and B, lanes 2 and
3).
The specificity of the first immunoprecipitation was shown by
precipitating from 35S-labeled cells. Immunoprecipitation
with polyclonal antibodies against NCAM demonstrated the presence of
NCAM 140 and some NCAM 120 in bottom gradient fractions (Fig.
3A, lane 1) and exclusively NCAM 120 in DIG fractions (Fig. 3A, lane 4). In
the DIG fraction, an additional signal at 59 kDa was observed and
represents 35S-labeled Fyn protein. Immunoprecipitation
with polyclonal antibodies against F3 yielded a weak signal from bottom
fractions of the gradient (Fig. 3B, lane
1), but a strong F3 signal was observed in the DIG fraction
(Fig. 3B, lane 4). As in the case for
NCAM 120, an additional signal at 59 kDa of 35S-labeled Fyn
protein was also seen in the F3 precipitate from the DIG fraction. To
ensure that Fyn was indeed present in these bottom gradient fractions,
Western blots were performed on the fractions. These results (Fig.
3C, lane 2) confirmed the presence of
Fyn in the bottom fractions, as is also shown in Fig. 1. Additionally, Western blots with antibodies against NCAM and F3 demonstrated the
presence of NCAM (lane 1) and F3 (lane
3) in these fractions.
This high affinity association of NCAM 120 and F3 with Fyn kinase is
thus specific to the DIGs and identifies these adhesion molecules as
potential effectors regulating the activity of Fyn in DIGs.
Antibody-mediated Cross-linking of Oligodendroglial F3 Stimulates
Fyn Activity in DIGs--
To simulate ligation of F3 by
e.g. axonal ligands, we examined the effect of
antibody-mediated cross-linking of F3 on living cells on the tyrosine
phosphorylation of Fyn in oligodendrocytes. To ensure high yields of
material and thus examination of several time points, we used the
oligodendroglial cell line Oli-neu, after incubation in the
presence of 1 mM dbcAMP to induce differentiation (34).
This treatment also up-regulates the DIGs. Differentiated Oli-neu cells were incubated at 4 °C with a monoclonal
antibody binding to the Ig domains of the F3 molecule, followed by a
species-specific secondary antibody. Subsequently, the cells were
transferred to 37 °C and incubated further for different periods of
time. Cells were then immediately lysed and subjected to sucrose
density gradient centrifugation. DIGs as well as bottom fractions were
recovered from the gradient and analyzed by Western blot for the
presence of phosphorylation on tyrosine of Fyn as a measure of kinase
activation and of total Fyn protein. Tyrosine-phosphorylated Fyn in the
DIG fractions increased with time of incubation of the cells at
37 °C, while the total amount of Fyn protein in DIGs remained
unchanged (Fig. 4A,
right panels a and b). The
Fyn activity reached a transient maximum between 3 and 5 min of
incubation at 37 °C and then subsequently declined. Interestingly,
incubation with the primary antibody alone at 37 °C activated Fyn,
while control incubations with secondary antibody alone had no effect
on Fyn activity (data not shown). In contrast to the changes in Fyn
phosphorylation seen in the DIG fraction, the tyrosine phosphorylation
of proteins including Fyn present in bottom gradient fractions is not
affected by cross-linking F3 (Fig. 4A, left
panels a and b). The densitometric
quantification of the increase in tyrosine phosphorylation of Fyn
related to the total Fyn protein levels in DIGs showed variations in
the degree of stimulation of Fyn activity between different
experiments, with up to 8-fold increase of activity. Nevertheless, all
experiments showed that ligation of F3 on the oligodendroglial cell
surface results in an activation of Fyn kinase strictly localized to
DIGs.
As an additional control, monoclonal antibody to the 330-kDa cell
surface glycoprotein AN2, which is expressed by these cells (31), was
used in similar cross-linking experiments (Fig. 4B). In
contrast to the results seen with antibody to F3, no stimulation of Fyn
kinase activity was seen in the DIG fraction or the bottom fractions of
the gradient. Immunoprecipitation experiments with AN2 antibody from
35S-labeled cells further show that Fyn and AN2 do not
associate (Ref. 31; Fig. 4C); no Fyn protein is seen in the
immunoprecipitate of AN2 from differentiated Oli-neu cells.
These experiments demonstrate that the activation of Fyn in DIGs by
cross-linking F3 is specific and not due to cross-linking just any cell
surface protein.
Glycosphingolipid-rich Membrane Microdomains as a Signaling
Platform in Oligodendrocytes--
We have shown that in DIGs from both
oligodendrocytes and myelin the Src family kinases Fyn and Lyn
colocalize with the GPI-anchored proteins NCAM 120 and F3, suggesting
their association with raftlike microdomains during development of the
myelin sheath.
DIGs containing Src kinases were first isolated from lymphocytes by
Cinek and Horejsi (39) and were subsequently isolated from many cell
types (25, 40). It was postulated that these detergent-isolated
complexes correspond to functional microdomains or rafts in the plasma
membrane important for the compartmentation of distinct cellular
functions including signal transduction pathways (17, 18, 41-47). The
existence in vivo of raft-like microdomains has been a
subject of discussion (48). However, recent studies have supported the
existence of small domains in living cells (49-51). The detailed
cellular functions and in particular the downstream targets of these
signaling domains remain unelucidated in most cell types. Recent papers
have shown that for efficient T-cell activation, a striking
compartmentation in DIGs of activated T-cell receptor and
signal-transducing molecules is essential, stressing the role of rafts
as functional signaling domains in lymphocytes (46, 47).
A Role of Rafts in Fyn and Lyn Signaling during the Initiation
Phase of Myelination--
We have shown that the total kinase activity
in DIGs as measured by a kinase assay, as well as the specific kinase
activity of Fyn and Lyn is developmentally regulated parallel to the
in vivo myelination process. The clear peak of Fyn and Lyn
activity in DIGs isolated from oligodendrocytes and myelin of young
postnatal animals (P9/10 mice) suggests its role in the initiation of
the myelination program.
The expression of Fyn in oligodendrocytes and myelin and its early
postnatal activity have been described before (15, 52). Fyn knockout
mice are hypomyelinated; the myelin content normalized for brain weight
is 40-50% reduced compared with wild-type mice. Ligation of MAG, a
cell adhesion molecule thought to play a role in early axon-glia
recognition (6), was reported to stimulate Fyn activity and was a
substrate for Fyn phosphorylation (15). Since MAG is not present in
oligodendroglial DIGs,2 it
can be excluded as a substrate for Fyn activity in DIGs. Our results
thus argue for the existence of an additional MAG-independent signaling
pathway of Fyn using raftlike microdomains as signaling compartments.
The Stable Association of F3 and NCAM 120 with Fyn in
Oligodendrocytes Is Exclusive to Rafts--
We find Fyn kinase
activity associated with both NCAM 120 and F3 in immunoprecipitates
from isolated DIGs. The complex is stable in SDS-containing buffer
under stringent conditions that destroy the DIG complexes, stressing
the affinity of the interactions between these molecules. F3, NCAM 120, and Fyn also are present outside the DIGs. However, Fyn is not
associated with immunoprecipitates of F3 or NCAM from non-DIG fractions
of oligodendrocytes (e.g. immunoprecipitates from bottom
gradient fractions or DIG-free precursor cells). The stable association
between these molecules is thus exclusive to DIGs. Staining of cultured
oligodendrocytes shows co-localization of a fraction of F3 and Fyn with
galactocerebroside (29),3 the
main DIG lipid (16).
An interaction between NCAM and Fyn has been reported recently in
growth cones of neurons, but Fyn was associated exclusively with the
transmembrane isoform NCAM 140 and not with the GPI-anchored isoform
NCAM 120 (53). The interaction between F3 or F11 (the chicken homolog)
and Fyn has also been described for mouse cerebellar tissue and chick
embryonal brain cells, respectively (54, 55).
Local Fyn Signaling in Rafts Is Evoked by Ligation of
Oligodendroglial F3--
Ligation of cell surface receptors including
GPI-anchored proteins with specific antibodies has been used to mimic
the interaction with unknown ligands and to induce cellular responses,
especially in lymphocytes (24, 39). Ligation of F3 by antibody-mediated cross-linking in differentiated Oli-neu cells induces a
transient increase of Fyn activity (up to 8.5-fold), which is strictly
localized to DIGs. The activation is rapid, and the Fyn kinase activity is rapidly down-regulated. Other proteins phosphorylated on tyrosine are also found in the DIG and the bottom fractions of the gradient; however, a change in their phosphorylation after cross-linking F3 was
not detected in this assay. A stimulation of kinase activity after
antibody-mediated cross-linking of F3 was shown in two other studies
using primary chicken neuroblasts (54) and transfected cells (55). In
these studies, an in vitro kinase assay was performed on
immunoprecipitates. In contrast, we show the in situ
stimulation of Fyn kinase in intact oligodendroglial cells after
ligation of cell surface F3. We also show that this transmembrane
signaling event is localized to a specified membrane subdomain, the
raft-like microdomains.
Mechanisms of Kinase Activation and Axonal Ligands--
It is
still an open question how exoplasmic GPI-anchored proteins interact
with cytoplasmic membrane-associated Src kinases, leading to signal
transmission across the membrane. Harder et al. (18, 51)
suggested that the clustering of GPI-anchored proteins by ligands may
aggregate individual small rafts into larger domains, leading to a
focal concentration of kinase activity at the cytoplasmic face of the
membrane. Alternatively, a transmembrane protein may link F3 and Fyn.
Such a protein could be developmentally regulated and may also regulate
the activity of the kinase (24, 25). The stability of the F3 and NCAM
120 associations with Fyn in our experiments argues for the presence of
a transmembrane linker protein. Contactin-associated protein
(Caspr/paranodin; Refs. 57 and 58), a member of the neurexin
superfamily, has been described as a cis interaction partner of F3 in
neurons (59). In oligodendrocytes that do not appear to express Caspr
(30), other candidates may link F3 and Fyn. These may include receptor protein tyrosine phosphatase Distinct Signaling Pathways Associate with NCAM 120 and F3 during
Oligodendrocyte Differentiation--
In oligodendrocyte precursor
cells, DIGs and consequently the F3-Fyn complex are lacking due to the
low expression of glycosphingolipids (see as a model Fig.
5). With maturation to
myelination-competent oligodendrocytes and the accompanying
up-regulation of glycosphingolipids, the F3-Fyn complex forms as DIGs
are up-regulated. A similar maturation-dependent signaling-concept has been suggested for the axonal adhesion molecule axonin-1, which is also a GPI-anchored protein (63). Axonin-1 associates with Fyn kinase in neurons of the chick dorsal root ganglion, while neurites are growing. During fasciculation of the
neurites, which is mediated by interactions of axonin-1 and NgCAM,
axonin-Fyn complexes dissociate, and axonin predominantly associates
with NgCAM in large macromolecular complexes containing casein kinase
activity. Our study thus underscores the premise that the coordinated
association of cell surface receptors with distinctive signaling
molecules in specialized membrane compartments allows these molecules
to adjust their function to changing requirements during development.
Coupling F3 and NCAM 120 to the Fyn signaling complex may initiate
progression of a premyelinating oligodendrocyte to a myelinating
oligodendrocyte. The lateral mobility of GPI-anchored proteins in the
membrane may support their flexibility in interacting with different
cis-binding partners. Targets of activated Fyn could ultimately include
cytoskeletal proteins, since wrapping of the oligodendrocyte processes
around the axon must involve dramatic changes in the cell cytoskeleton
(64). In support of this concept, a recent publication (52) has shown
that inhibiting Fyn prevents process outgrowth by oligodendrocytes.
Our findings yield new insights into the molecular basis of
oligodendrocyte-axon interaction and subsequent glial signaling transduction cascades that may instruct the oligodendroglial
myelination program.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]ATP, L-[35S]Met/Cys
in vitro labeling mix) and ECL reagents were from Amersham
Pharmacia Biotech (Braunschweig, Germany); human recombinant
platelet-derived growth factor (AA) and basic fibroblast growth factor
were from TEBU (Frankfurt, Germany); dibutyryl cyclic AMP (dbcAMP),
Triton X-100, Nonidet P-40, and sodium deoxycholate were from Sigma
(Deisenhofen, Germany); Protein A-Sepharose CL4B was from Amersham
Pharmacia Biotech (Freiburg, Germany); Bradford reagent for protein
assays was from Bio-Rad (München, Germany); polyvinylidene
difluoride membrane was from Millipore (Bedford, MA). The
amino-terminal peptide of F3 (KGFGPIFEEQPINT) was synthesized by Dr. R. Frank (ZMBH, University of Heidelberg, Germany).
80 °C. The protein content of the myelin
preparations was determined by using the Bio-Rad protein assay with
bovine serum albumin as a protein standard.
-32P]ATP in vitro kinase assay. To
identify associated kinases, some samples were subjected to a second
round of immunoprecipitation; immune complexes were denatured and
dissociated by two sequential incubations in 50 µl of 50 mM Tris/HCl, pH 7.4, 0.5% SDS, and 1%
-mercaptoethanol
for 10 min at 95 °C followed by centrifugation. Supernatants eluted
from the Sepharose beads were diluted in 500 µl of lysis buffer and
incubated with Fyn antibodies and Protein A-Sepharose for 1 h at room temperature. All samples were analyzed by SDS-PAGE, and
radioactive protein bands were detected with a phosphoimager or autoradiography.
-32P]ATP kinase
assay were immunoprecipitated with antibodies against Fyn and Lyn
according to the same procedure, but SDS-PAGE analysis was performed
directly after the precipitation.
-32P]ATP for 20 min at room temperature.
The samples were washed and subjected either to SDS-PAGE or a second
round of immunoprecipitation to identify associated kinases.
-32P]ATP for 20 min at room temperature. Kinase
assays were analyzed by SDS-PAGE and autoradiography or subjected to immunoprecipitation.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (28K):
[in a new window]
Fig. 1.
Colocalization of GPI-anchored proteins with
Src family kinases in detergent-insoluble complexes
from oligodendrocytes and myelin during development. Triton X-100
extracts prepared from oligodendrocytes and myelin from mice of
different ages were prepared at 4 °C, adjusted to 40% sucrose, and
loaded on a 5-30% linear sucrose density gradient. Equal amounts of
total protein (300 µg) were loaded on the gradients of the different
myelin preparations. Gradient fractions were collected, subjected to
SDS-PAGE, and analyzed by Western blot for the distribution of the
GPI-anchored proteins NCAM 120 and F3 (A) and for the Src
family tyrosine kinases Fyn and Lyn (B). Fraction 1 is of
high density from the bottom of the gradient. DIGs from
oligodendrocytes and myelin are heterogeneous in density, whereas DIGs
from mature myelin are quite homogeneous. The Src family kinase Fyn
colocalizes with GPI-anchored proteins in DIGs from oligodendrocytes
and myelin of all developmental stages. Lyn kinase is present in DIGs
from oligodendrocytes and myelin from P9/10, and P12 mice and is
down-regulated in DIGs from myelin from older mice.
-32P]ATP kinase assays of
DIGs with antibodies directed against the Src family kinases Fyn and
Lyn showed that both participate in the kinase reactions and are
phosphorylated. The phosphorylation of both these kinases in DIGs is
down-regulated with ongoing myelination (Fig.
2A). The strongest signal for
32P-phosphorylated Fyn was obtained in precipitates of Fyn
from oligodendrocyte DIGs. The 32P phosphorylation of Fyn
in DIGs from myelin continuously declined between P9/10 and P30 and was
virtually absent in DIGs from myelin of P45 and adult mice. High
amounts of 32P-phosphorylated Lyn were precipitated from
DIGs from oligodendrocytes, whereas only very weak 32P
signals were obtained from DIGs of myelin from P9/10 and P12 mice. To
investigate whether the reduction in phosphorylation of the kinases is
due to a reduction in expression of the respective proteins, the
samples were analyzed by Western blotting. Significant levels of Fyn
kinase were present in myelin DIGs throughout development until adult
(Fig. 2B). In contrast, expression of Lyn kinase was observed in myelin DIGs up to P12 and was thereafter absent. The phosphorylation of Src family kinases is in most cases due to autophosphorylation and can be taken as a measure of the enzymatic activity (38). We measured the optical densities of the autoradiograms showing the 32P phosphorylation as well as the optical
densities of the signals from the Western blots showing the total
amount of the kinases and expressed the activity of each kinase as
relative phosphorylation per unit of protein (Fig. 2C). The
kinase activity of Fyn is highest in DIGs from oligodendrocytes and in
DIGs from myelin of P9/10 mice, at a time point where in
vivo myelination is commencing. With ongoing myelination, the Fyn
activity localized in DIGs is rapidly down-regulated. Lyn kinase
activity is maximal in DIGs from cultured oligodendrocytes and weak in
DIGs from myelin of P9/10 and P12 mice.

View larger version (45K):
[in a new window]
Fig. 2.
Analysis of Fyn and Lyn kinase activity in
DIGs from oligodendrocytes and myelin. Isolated DIGs from
oligodendrocytes and myelin from mice of different ages were subjected
to a [
-32P]ATP kinase assay. Phosphorylated Fyn
(left) and Lyn (right) were analyzed by
immunoprecipitation (A) and compared with total Fyn and Lyn
protein in the same samples analyzed by Western blot (B).
The relative phosphorylation per unit of protein (relative kinase
activity) of Fyn and Lyn was calculated by densitometric quantification
of the immunoprecipitation in A and the Western blot in
B (C). The kinase activity of Fyn in myelin DIGs
is maximal at P9/10. Lyn activity is most prominent in DIGs from
cultured oligodendrocytes.
-32P]-ATP in vitro kinase assay on the
immunoprecipitate. The bottom fractions of the gradient were also
isolated and similarly subjected to immunoprecipitation and kinase
assay. Phosphorylated proteins associated with the immunoprecipitate
were separated by SDS-PAGE and visualized by autoradiography.

View larger version (33K):
[in a new window]
Fig. 3.
Co-immunoprecipitation of Fyn kinase with
NCAM 120 and F3 from isolated DIGs. Oligodendrocyte DIGs were
isolated from sucrose density gradients and subjected to
immunoprecipitation using specific antibodies recognizing NCAM
(A) or F3 (B). Immunoprecipitates were subjected
to a [
-32P]ATP in vitro kinase assay and
analyzed by SDS-PAGE followed by autoradiographic detection of
phosphorylated proteins. Alternatively, the bottom gradient fractions
were taken and similarly treated. The 59-kDa phosphoprotein
co-precipitating with the GPI-anchored proteins NCAM 120 and F3 in the
DIG fractions was identified by reprecipitation with antibodies
specific for Fyn kinase (lane 6, A and
B). As an alternative to the kinase assays, the same
fractions (DIGs and bottom) were collected from gradients of cells that
had been incubated with 35S translabel, subjected to
immunoprecipitation with polyclonal antibodies against NCAM and F3 and
analyzed by SDS-PAGE and phosphoimager detection (lanes 1 and 4, A and B).
C, to further demonstrate the presence of Fyn, F3 and NCAM
in the bottom fractions, 75-µl aliquots of the bottom fraction of the
gradient were subjected to Western blotting with polyclonal antibodies
against F3, NCAM, and Fyn. wblot with ab, Western blot with
antibody.

View larger version (18K):
[in a new window]
Fig. 4.
Cross-linking F3 molecules up-regulates Fyn
activity. A, Oli-neu cells, after
differentiation in the presence of 1 mM dbcAMP, were
incubated at 4 °C with the monoclonal antibody 27-11-111 recognizing
F3 followed by a secondary anti-mouse antibody. The cultures were then
incubated at 37 °C for 0, 3, 5, and 10 min and lysed. The DIGs and
bottom fractions were isolated from gradients and analyzed by Western
blot with antibodies against phosphotyrosine (a), Fyn
(b), and F3 (c). The band shown in a
is the signal of tyrosine phosphorylated Fyn protein. While the total
amount of Fyn protein is unchanged, the tyrosine phosphorylation of Fyn
in DIGs increases to a maximum after 5 min at 37 °C. The
asterisk marks a signal due to reactivity with the heavy
chain of the secondary anti-mouse antibody used in the cross-link. The
experimental design is shown schematically. B, as a control,
Oli-neu cells, after differentiation in the presence of 1 mM dbcAMP, were incubated at 4 °C with the monoclonal
antibody AN2 followed by secondary anti-rat antibody. The cells were
lysed immediately or after incubation at 37 °C for 5 min, and the DIG and bottom sucrose
density gradient fractions blotted with antibodies to phosphotyrosine
(a) or Fyn protein (b). The band shown in
a is the signal of tyrosine phosphorylated Fyn protein.
C, differentiated Oli-neu cells (as above) were
subjected to metabolic radiolabeling and immunoprecipitation with
polyclonal AN2 antibody. In lane 1, the
immunoprecipitated AN2 at around 330 kDa is seen. Lanes 2 and 3 show Western blots of these
immunoprecipitates with monoclonal AN2 antibody (lane 2) and with monoclonal antibody to Fyn (lane 3). The total lysate of the differentiated
Oli-neu cells prior to immunoprecipitation was blotted with
monoclonal antibody to Fyn (lane 4). wblot
with ab, Western blot with antibody.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
and members of the L1 family, some of
which are expressed by oligodendrocytes (60, 61). Axonal interaction
partners of NCAM 120 and F3 serving as putative ligands to induce the
Fyn signaling cascade are the axonally expressed adhesion molecules
NCAM itself (homophilic interaction) and L1 (heterophilic interaction
with F3). L1 has been found in a complex together with F3 and Fyn in
isolates from cerebellar tissue (62). Furthermore, F3-positive
Oli-neu cells adhere to an L1-positive substrate, and this
adhesion can be substantially reduced by the addition of antibodies to
F3 (data not shown).

View larger version (36K):
[in a new window]
Fig. 5.
Model of NCAM 120 and F3 signaling complexes
during oligodendrocyte development. 1, oligodendrocyte
precursor cells express F3, NCAM 120 (and NCAM 140) and Fyn, but these
molecules are not stably associated. 2, in maturing
oligodendrocytes, NCAM 120 and F3 are associated with Fyn in the DIG
fraction, which can be isolated from these cells as oligodendrocyte
glycosphingolipids (GSL) are up-regulated. NCAM 140 is not
included in these complexes. The ligation of F3 (and possibly NCAM 120)
in these complexes by an axonal ligand activates oligodendroglial Fyn.
This is reflected in an increased autophosphorylation of Fyn.
3, in mature oligodendrocytes and myelin, the kinase
activity of Fyn is reduced.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Doris Kendel and Iris Bünzli-Ehret for excellent technical help. Fritz Rathjen is thanked for the valuable gift of the 27-11-111 anti-F3/F11 monoclonal antibody. Our colleagues, especially Kai Simons, Klaus-Armin Nave, Nicole Schaeren-Wiemers, Christoph Thiele, Jeremy Garwood, and Bruno Kyewski, are thanked for critically reading and commenting on the manuscript. J. T. thanks Wieland Huttner for stimulating discussions and support.
| |
FOOTNOTES |
|---|
* This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 317 (to J. T.) and Graduiertenkolleg "Molekulare und Zelluläre Neurobiologie" Stipendia (to C. K. and T. K.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Present address: Proctor and Gamble European Service GmbH,
Industriestr. 30-34, 65760 Eschborn, Germany.
§ To whom correspondence should be addressed. Tel.: 49-6221-548319; Fax: 49-6221-548301; E-mail: jtrotter@sun0.urz.uni-heidelberg.de.
2 E.-M. Krämer and J. Trotter, unpublished results.
3 E.-M. Krämer and J. Trotter, unpublished observations.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: NCAM, neural cell adhesion molecule; DIGs, detergent-insoluble glycosphingolipid-rich microdomains; GPI, glycosylphosphatidylinositol; MAG, myelin-associated glycoprotein; Pn, postnatal day n; dbcAMP, dibutyryl cyclic AMP; PAGE, polyacrylamide gel electrophoresis.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Hildebrand, C., Remahl, S., Persson, H., and Bjartmar, C. (1993) Prog. Neurobiol. 40, 319-384[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Raff, M. C., Miller, R. H., and Noble, M. (1983) Nature 303, 390-396[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Behar, T., McMorris, F. A., Novotny, E. A., Barker, J. L., and Dubois-Dalcq, M. (1988) J. Neurosci. Res. 21, 168-180[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Pfeiffer, S. E., Warrington, A. E., and Bansal, R. (1993) Trends Cell Biol. 3, 191-197[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Lubetzki, C.,
Demerens, C.,
Anglade, P.,
Villarroya, H.,
Frankfurter, A.,
Lee, V. M. Y.,
and Zalc, B.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
6820-6824 |
| 6. | Meyer-Franke, A., and Barres, B. (1994) Curr. Biol. 4, 847-850[Medline] [Order article via Infotrieve] |
| 7. | Doyle, J. P., and Colman, D. R. (1993) Curr. Opin. Cell Biol. 5, 779-785[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Notterpek, L. M., and Rome, L. H. (1994) Neuron 13, 473-485[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | de Waegh, S. M., Lee, V. M. Y., and Brady, S. T. (1992) Cell 68, 451-463[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Hsieh, S. T., Kidd, G. J., Crawford, T. O., Xu, Z., Lin, W. M., Trapp, B. D., Cleveland, D. W., and Griffin, J. W. (1994) J. Neurosci. 14, 6392-6401[Abstract] |
| 11. | Payne, H. R., Hemperly, J. J., and Lemmon, V. (1996) Dev. Brain Res. 97, 9-15[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Li, C., Tropak, M. B., Gerlai, R., Clapoff, S., Abramow-Newerly, W., Trapp, B., Peterson, A., and Roder, J. (1994) Nature 369, 747-750[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Montag, D., Giese, K. P., Bartsch, U., Martini, R., Lang, Y., Blüthmann, H., Karthigasan, J., Kirschner, D. A., Wintergerst, E. S., Nave, K. A., Zielasek, J., Toyka, K. V., Lipp, H. P., and Schachner, M. (1994) Neuron 13, 229-246[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Carenini, S., Montag, D., Cremer, H., Schachner, M., and Martini, R. (1997) Cell Tissue Res. 287, 3-9[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Umemori, H., Sato, S., Yagi, T., Aizawa, S., and Yamamoto, T. (1994) Nature 367, 572-576[CrossRef][Medline] [Order article via Infotrieve] |
| 16. |
Krämer, E.-M.,
Koch, T.,
Niehaus, A.,
and Trotter, J.
(1997)
J. Biol. Chem.
272,
8937-8945 |
| 17. | Simons, K., and Ikonen, E. (1997) Nature 387, 569-572[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Harder, T., and Simons, K. (1997) Curr. Opin. Cell Biol. 9, 534-542[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Brown, D. A., and Rose, J. K. (1992) Cell 68, 533-544[CrossRef][Medline] [Order article via Infotrieve] |
| 20. |
Bosio, A.,
Binczek, E.,
and Stoffel, W.
(1996)
Proc. Natl. Sci. U. S. A.
93,
13280-13285 |
| 21. | Coetzee, T., Fujita, N., Dupree, J. L., Shi, R., Blight, A., Susuki, Ki, Susuki, Ku, and Popko, B. (1996) Cell 86, 209-219[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Dupree, J. L.,
Coetzee, T.,
Blight, A.,
Susuki, K.,
and Popko, B.
(1998)
J. Neurosci.
18,
1642-1649 |
| 23. | Coetzee, T., Susuki, K., and Popko, B. (1998) Trends Neurosci. 21, 126-130[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Robinson, P. J. (1991) Immunology Today 12, 35-41[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Brown, D. A. (1993) Curr. Opin. Immunol. 5, 349-354[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Bhat, S., and Silberberg, D. H. (1986) J. Neurosci. 6, 3348-3354[Abstract] |
| 27. | Trotter, J., Bitter-Suermann, D., and Schachner, M. (1989) J. Neurosci. Res. 22, 369-383[CrossRef][Medline] [Order article via Infotrieve] |
| 28. |
Gennarini, G.,
Cibelli, G.,
Rougon, G.,
Mattei, M. G.,
and Goridis, C.
(1989)
J. Cell Biol.
109,
775-788 |
| 29. | Koch, T., Brugger, T., Bach, A., Gennarini, G., and Trotter, J. (1997) Glia 19, 199-212[CrossRef][Medline] [Order article via Infotrieve] |
| 30. |
Einheber, S.,
Zanazzi, G.,
Ching, W.,
Scherer, S.,
Milner, T. A.,
Peles, E.,
and Salzer, J. L.
(1997)
J. Cell Biol.
139,
1495-1506 |
| 31. |
Niehaus, A.,
Stegmüller, J.,
Diers-Fenger, M.,
and Trotter, J.
(1999)
J. Neurosci.
19,
4948-4961 |
| 32. | Brümmendorf, T., Hubert, M., Treubert, U., Leuschner, R., Tarnok, A., and Rathjen, F. G. (1993) Neuron 10, 711-727[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Sontheimer, H., Trotter, J., Schachner, M., and Kettenmann, H. (1989) Neuron 2, 1135-1145[CrossRef][Medline] [Order article via Infotrieve] |
| 34. | Jung, M., Krämer, E. M., Grzenkowski, M., Tang, K., Blakemore, W., Aguzzi, A., Khazaie, K., Chlichlia, K., von Blankenfeld, G., Kettenmann, H., and Trotter, J. (1995) Eur. J. Neurosci. 7, 1245-1265[CrossRef][Medline] [Order article via Infotrieve] |
| 35. | Smith, M. E. (1969) J. Neurochem. 16, 83-92[CrossRef][Medline] [Order article via Infotrieve] |
| 36. | Norton, W. T., and Poduslo, S. E. (1973) J. Neurochem. 21, 749-757[Medline] [Order article via Infotrieve] |
| 37. |
Sargiacomo, M.,
Sudol, M.,
Tang, Z.,
and Lisanti, M. P.
(1993)
J. Cell Biol.
122,
789-807 |
| 38. | Thomas, S. M., and Brugge, J. S. (1997) Annu. Rev. Cell Dev. Biol. 13, 513-609[CrossRef][Medline] [Order article via Infotrieve] |
| 39. | Cinek, T., and Horejsi, V. (1992) J. Immunol. 149, 2262-2270[Abstract] |
| 40. | Vaughan, L. (1996) Semin. Neurosci. 8, 397-403 |
| 41. |
Stefanova, I.,
Horejsi, V.,
Ansotegui, I. J.,
Knapp, W.,
and Stockinger, H.
(1991)
Science
254,
1016-1019 |
| 42. | Shenoy-Scaria, A. M., Kwong, J., Fujita, T., Olszowy, M. W., Shaw, A. S., and Lublin, D. M. (1992) J. Immunol. 149, 3535-3541[Abstract] |
| 43. | Garnett, D., Barclay, A. N., Carmo, A. M., and Beyers, A. D. (1993) Eur. J. Immunol. 23, 2540-2544[Medline] [Order article via Infotrieve] |
| 44. |
Thomas, P. M.,
and Samelson, L. E.
(1992)
J. Biol. Chem.
267,
12317-12322 |
| 45. |
Draberova, L.,
and Draber, P.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
3611-3615 |
| 46. | Xavier, R., Brennan, T., Li, Q., McCormack, C., and Seed, B. (1998) Immunity 8, 723-732[CrossRef][Medline] [Order article via Infotrieve] |
| 47. |
Viola, A.,
Schroeder, S.,
Sakakibara, Y.,
and Lanzavecchia, A.
(1999)
Science
283,
680-682 |
| 48. | Hooper, N. M. (1998) Curr. Biol. 8, R114-R116[CrossRef][Medline] [Order article via Infotrieve] |
| 49. | Brown, R. E. (1998) J. Cell Sci. 111, 1-9[Abstract] |
| 50. | Sheets, E. D., Lee, G. M., Simson, R., and Jacobson, K. (1997) Biochemistry 36, 12449-12458[CrossRef][Medline] [Order article via Infotrieve] |
| 51. |
Harder, T.,
Scheiffele, P.,
Verkade, P.,
and Simons, K.
(1998)
J. Cell Biol.
141,
929-942 |
| 52. |
Osterhout, D. J.,
Wolven, A.,
Wolf, R. M.,
Resh, M. D.,
and Chao, M. V.
(1999)
J. Cell Biol.
145,
1209-1218 |
| 53. |
Beggs, H. E.,
Baragona, S. C.,
Hemperly, J. J.,
and Maness, P. F.
(1997)
J. Biol. Chem.
272,
8310-8319 |
| 54. | Zisch, A. H., D'Alessandri, L., Amrein, K., Ranscht, B., Winterhalter, K. H., and Vaughan, L. (1995) Mol. Cell. Neurosci. 6, 263-279[CrossRef][Medline] [Order article via Infotrieve] |
| 55. |
Cervello, M.,
Matranga, V.,
Durbec, P.,
Rougon, G.,
and Gomez, S.
(1996)
J. Cell Sci.
109,
699-704 |
| 56. | Koch, T. (1998) Untersuchungen zu Oligodendroglialen Glykosylphosphatidylinositol-Verankerken Molekülen, mit Besonderem Angenmerk auf die Expression von F3.Ph.D. thesis , University of Heidelberg |
| 57. | Menegoz, M., Gaspar, P., Le Bert, M., Galvez, T., Burgaya, F., Palfrey, C., Ezan, P., Arnos, F., and Girault, J. A. (1997) Neuron 19, 319-331[CrossRef][Medline] [Order article via Infotrieve] |
| 58. | Peles, E., Nativ, M., Campbell, P. L., Sakurai, T., Martinez, R., Lev, S., Clary, D. O., Schilling, J., Barnea, G., Plowman, G. D., Grumet, M., and Schlessinger, J. (1995) Cell 82, 251-260[CrossRef][Medline] [Order article via Infotrieve] |
| 59. | Peles, E., Nativ, M., Lustic, M., Grumet, M., Schilling, J., Martinez, R., Plowman, G. D., and Schlessinger, J. (1997) EMBO J. 16, 978-988[CrossRef][Medline] [Order article via Infotrieve] |
| 60. | Takeda, Y., Asou, H., Murakami, Y., Miura, M., Kobayashi, M., and Uyemura, K. (1996) J. Neurochem. 66, 2338-2349[Medline] [Order article via Infotrieve] |
| 61. | Collinson, J. M., Marshall, D., Gillespie, C. S., and Brophy, P. J. (1998) Glia 23, 11-23[CrossRef][Medline] [Order article via Infotrieve] |
| 62. | Olive, S., Dubois, C., Schachner, M., and Rougon, G. (1995) J. Neurochem. 65, 2307-2317[Medline] [Order article via Infotrieve] |
| 63. |
Kunz, S.,
Ziegler, U.,
Kunz, B.,
and Sonderegger, P.
(1996)
J. Cell Biol.
135,
253-267 |
| 64. | Brophy, P. J., Gillespie, S., Kelly, B. M., and Vouyiouklis, D. A. (1994) A Multidisciplinary Approach to Myelin Diseases II , pp. 71-82, Plenum Press, New York |